Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Equity Ratio (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Equity Ratio for 16 consecutive years, with 4.53 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 27.73% to 4.53 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.53 through Dec 2025, down 27.73% year-over-year, with the annual reading at 4.53 for FY2025, 27.73% down from the prior year.
  • Equity Ratio hit 4.53 in Q4 2025 for Guided Therapeutics, up from 6.31 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.68 in Q3 2022 to a low of 6.31 in Q3 2025.
  • Historically, Equity Ratio has averaged 3.22 across 5 years, with a median of 3.47 in 2021.
  • Biggest five-year swings in Equity Ratio: surged 89.14% in 2021 and later plummeted 183.95% in 2023.
  • Year by year, Equity Ratio stood at 2.67 in 2021, then surged by 67.91% to 0.86 in 2022, then tumbled by 166.25% to 2.28 in 2023, then crashed by 55.58% to 3.55 in 2024, then fell by 27.73% to 4.53 in 2025.
  • Business Quant data shows Equity Ratio for GTHP at 4.53 in Q4 2025, 6.31 in Q3 2025, and 5.82 in Q2 2025.